Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 24Breast Neoplasms 22Multiple Myeloma 11Neoplasm Metastasis 9Pain 8Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Bone Neoplasms 5Osteoporosis 4Fractures, Bone 4Bone Diseases 4Lung Neoplasms 3Bone Diseases, Metabolic 3Spinal Cord Compression 2Humoral Hypercalcemia Of Malignancy 2Treatment of Bone Metastases 1Small Cell Lung Carcinoma 1Renal Insufficiency 1Pleural Effusion, Malignant 1Paraproteinemias 1Neoplastic Processes 1Neoplastic Cells, Circulating 1Neoplasms, Plasma Cell 1Neoplasm, Residual 1Lymphoma 1Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors 1Hematologic Neoplasms 1Hematologic Diseases 1Disease Progression 1Carcinoma, Renal Cell 1

Interventions

Dexamethasone 4pomalidomide 2Azacitidine 2vinflunine 1trifluridine tipiracil drug combination 1trebananib 1safinamide 1sacubitril and valsartan sodium hydrate drug combination 1rubitecan 1ripretinib 1regorafenib 1pevonedistat 1pembrolizumab 1osimertinib 1mirabegron 1melflufen 1gallium 68 PSMA-11 1copanlisib 1carfilzomib 1belinostat 1belantamab mafodotin 1Zoledronic Acid 1Topotecan 1Tablets 1Sitagliptin Phosphate 1Pluvicto 1Paclitaxel 1Lenalidomide 1L-melphalanyl-p-L-fluorophenylalanine ethyl ester 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Renal Insufficiency × Zoledronic Acid × Clear all
NCT00434447 2017-02-27

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

Novartis

Phase 4 Completed
73 enrolled
BreastGenitourinaryPlasma cellSarcoma

Bone Neoplasms, Breast Neoplasms, Multiple Myeloma, Prostatic Neoplasms, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡